NCT03542773View on ClinicalTrials.gov

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 6, 2015

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
SchwannomasMalignant Tumors
Interventions
DRUG

18F-DCFPyL Injection

18F-DCFPyL with whole body PET/CT scan

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT03542773 - Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET | Biotech Hunter | Biotech Hunter